Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy

1. Romero-Sánchez, M.C.
2. Álvarez-Ríos, A.I.
3. Bernal-Morell, E.
4. Genebat, M.
5. Vera, F.
6. Benhnia, M.R.-E.-I.
7. Bravo-Urbieta, J.
8. Galera-Peñaranda, C.
9. De Pablo-Bernal, R.S.
10. Abad-Carrillo, M.A.
11. Leal, M.
12. Ruiz-Mateos, E.